AIMS: Medulloblastoma (MB) is the most common primitive neuroectodermal tumour (PNET) of the central nervous system. Although supratentorial PNET (sPNET) and MB are histologically similar, their clinical behaviour differs, sPNET being more aggressive than MB. The aim of this study was to determine whether sPNET and MB are genetically different entities. METHODS AND RESULTS: We investigated 32 PNET primary tumour samples (23 MB and nine sPNET) and four PNET cell lines, for the presence of CDKN2A homozygous deletions at exon 1-alpha of p16/INK4 and exon 1-beta of p14/ARF, and promoter hypermethylation of both genes. No homozygous deletion of either p16/INK4 or p14/ARF was demonstrated in any of the PNET primary tumour samples. Methylation of p16/INK4 was found in one of six sPNET and in one of 23 MB, while p14/ARF methylation was observed in three of six sPNET and in three of 21 MB. No methylation of p16/INK4 or p14/ARF was found in any of the PNET cell lines analysed. The three MB cell lines did not show p16/INK4 expression, and only the MB Daoy cell line (homozygously deleted at CDKN2A) presented loss of p14/ARF expression. CONCLUSIONS: Our results in this limited series of central PNET show that p14/ARF is frequently involved in PNET carcinogenesis, with a higher frequency, but not statistically significant, for sPNET than for MB.
AIMS: Medulloblastoma (MB) is the most common primitive neuroectodermal tumour (PNET) of the central nervous system. Although supratentorial PNET (sPNET) and MB are histologically similar, their clinical behaviour differs, sPNET being more aggressive than MB. The aim of this study was to determine whether sPNET and MB are genetically different entities. METHODS AND RESULTS: We investigated 32 PNET primary tumour samples (23 MB and nine sPNET) and four PNET cell lines, for the presence of CDKN2A homozygous deletions at exon 1-alpha of p16/INK4 and exon 1-beta of p14/ARF, and promoter hypermethylation of both genes. No homozygous deletion of either p16/INK4 or p14/ARF was demonstrated in any of the PNET primary tumour samples. Methylation of p16/INK4 was found in one of six sPNET and in one of 23 MB, while p14/ARF methylation was observed in three of six sPNET and in three of 21 MB. No methylation of p16/INK4 or p14/ARF was found in any of the PNET cell lines analysed. The three MB cell lines did not show p16/INK4 expression, and only the MB Daoy cell line (homozygously deleted at CDKN2A) presented loss of p14/ARF expression. CONCLUSIONS: Our results in this limited series of central PNET show that p14/ARF is frequently involved in PNET carcinogenesis, with a higher frequency, but not statistically significant, for sPNET than for MB.
Authors: Adrian M Dubuc; Paul A Northcott; Stephen Mack; Hendrik Witt; Stefan Pfister; Michael D Taylor Journal: Curr Neurol Neurosci Rep Date: 2010-05 Impact factor: 5.081
Authors: Dmitri Wiederschain; Lin Chen; Brett Johnson; Kimberly Bettano; Dowdy Jackson; John Taraszka; Y Karen Wang; Michael D Jones; Michael Morrissey; James Deeds; Rebecca Mosher; Paul Fordjour; Christoph Lengauer; John D Benson Journal: Mol Cell Biol Date: 2007-04-23 Impact factor: 4.272
Authors: Marco Gessi; Gerrit H Gielen; Jennifer Hammes; Evelyn Dörner; Anja Zur Mühlen; Andreas Waha; Torsten Pietsch Journal: J Neurooncol Date: 2013-01-26 Impact factor: 4.130
Authors: Marco Gessi; André O von Bueren; Andras Treszl; Anja zur Mühlen; Wolfgang Hartmann; Monika Warmuth-Metz; Stefan Rutkowski; Torsten Pietsch Journal: Neuro Oncol Date: 2014-07 Impact factor: 12.300